Suppr超能文献

回顾性遗传学分析说明了活体相关供肾移植中常染色体显性遗传性 Alport 综合征的范围。

Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.

机构信息

Division of Nephrology, Department of Internal Medicine, University Hospital Leipzig, Liebigstr, 2004103, Leipzig, Germany.

Bioscientia, Institute of Human Genetics, Ingelheim, Germany.

出版信息

BMC Nephrol. 2019 Sep 2;20(1):340. doi: 10.1186/s12882-019-1523-7.

Abstract

BACKGROUND

Kidney transplantation is the treatment of choice in end-stage renal disease due to Alport syndrome (AS). However, the chances of finding an adequate living-related donor in AS are much worse compared to non-heritable conditions. Successful cases of related living-donor transplantation mostly refer to X-linked AS but are rarely reported in genetically confirmed autosomal AS.

CASE PRESENTATION

We describe the outcome of an exceptional AB0-incompatible kidney donation from father to son in a family with altered COL4A3. While decision-making was based on extensive clinical donor evaluation prior to transplantation, we analyzed the underlying genetic background in retrospect and associated these findings with the phenotype in all available family members. While biallelic COL4A3 variants caused autosomal recessive AS (ARAS) in the son (recipient), heterozygous family members, including the father (donor), showed minimal renal involvement and high-frequency sensorineural hearing impairment later in life indicating mild autosomal dominant Alport syndrome (ADAS). The recipient's successful participation in the European and World Transplant Games is a testament to the positive outcome of transplantation.

CONCLUSIONS

In summary, living-related donor transplantation may be successful in autosomal AS, provided that thorough clinical and genetic evaluation of potential donors is performed. However, unrelated kidney transplantation should be given priority upon unpredictable genetic risk. Individual genetic variant interpretation is an important component of personalized donor assessment and will help to better predict genetic risk in the future.

摘要

背景

由于 Alport 综合征(AS),肾移植是终末期肾病的首选治疗方法。然而,与非遗传性疾病相比,在 AS 中找到合适的活体亲属供体的机会要差得多。相关活体供体移植的成功案例主要涉及 X 连锁 AS,但在遗传确认的常染色体 AS 中很少有报道。

病例介绍

我们描述了一个特殊的 ABO 不相容的肾从父亲到儿子的活体供体移植的结果,这个家庭的 COL4A3 发生了改变。虽然在移植前进行了广泛的临床供体评估,但我们回顾性地分析了潜在的遗传背景,并将这些发现与所有可用的家庭成员的表型相关联。虽然双等位基因 COL4A3 变体导致儿子(受者)的常染色体隐性 AS(ARAS),但杂合子家庭成员,包括父亲(供体),在以后的生活中表现出轻微的肾脏受累和高频感音神经性听力损失,表明轻度常染色体显性 Alport 综合征(ADAS)。受者成功参加欧洲和世界移植运动会证明了移植的积极结果。

结论

总之,在进行彻底的临床和遗传评估后,活体亲属供体移植可能在常染色体 AS 中取得成功。然而,在不可预测的遗传风险下,应优先考虑无关肾移植。个体遗传变异的解释是个性化供体评估的重要组成部分,有助于更好地预测未来的遗传风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3037/6721183/7a80bd57ae1b/12882_2019_1523_Fig1_HTML.jpg

相似文献

2
Successful renal transplantation in a family with a novel mutation in COL4A3 gene and autosomal recessive Alport syndrome.
Nephrology (Carlton). 2020 Jun;25(6):497-501. doi: 10.1111/nep.13693. Epub 2020 Jan 29.
3
Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1441-1449. doi: 10.2215/CJN.01000116. Epub 2016 Jun 8.
5
Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
Am J Kidney Dis. 2021 Oct;78(4):560-570.e1. doi: 10.1053/j.ajkd.2021.02.326. Epub 2021 Apr 7.
6
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
Kidney Int. 2004 May;65(5):1598-603. doi: 10.1111/j.1523-1755.2004.00560.x.
7
Heterozygous Urinary Abnormality-Causing Variants of and Affect Severity of Autosomal Recessive Alport Syndrome.
Kidney360. 2020 Jul 16;1(9):936-942. doi: 10.34067/KID.0000372019. eCollection 2020 Sep 24.
8
Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.
Pediatr Nephrol. 2022 Sep;37(9):1981-1994. doi: 10.1007/s00467-022-05430-7. Epub 2022 Jan 27.
9

引用本文的文献

1
Renal transplantation in Alport syndrome.
Kidney Res Clin Pract. 2025 Jul;44(4):583-587. doi: 10.23876/j.krcp.24.143. Epub 2024 Nov 12.
2
A Current Landscape on Alport Syndrome Cases: Characterization, Therapy and Management Perspectives.
Biomedicines. 2023 Oct 12;11(10):2762. doi: 10.3390/biomedicines11102762.
3
Alport Syndrome and Oral Mucous Membrane Pemphigoid: An Interesting Case.
Cureus. 2023 Jul 7;15(7):e41519. doi: 10.7759/cureus.41519. eCollection 2023 Jul.
4
Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.
Curr Transplant Rep. 2022 Jun;9(2):127-142. doi: 10.1007/s40472-021-00340-3. Epub 2022 Mar 16.
5
Novel Therapies for Alport Syndrome.
Front Med (Lausanne). 2022 Apr 25;9:848389. doi: 10.3389/fmed.2022.848389. eCollection 2022.
6
Clinical Applications of Genetic Discoveries in Kidney Transplantation: a Review.
Kidney360. 2020 Mar 11;1(4):300-305. doi: 10.34067/KID.0000312019. eCollection 2020 Apr 30.
7
Guidelines for Genetic Testing and Management of Alport Syndrome.
Clin J Am Soc Nephrol. 2022 Jan;17(1):143-154. doi: 10.2215/CJN.04230321. Epub 2021 Dec 20.

本文引用的文献

1
Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous or Variant?
Kidney Int Rep. 2018 Aug 22;3(6):1239-1241. doi: 10.1016/j.ekir.2018.08.002. eCollection 2018 Nov.
2
Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation.
Int J Nephrol Renovasc Dis. 2018 Oct 16;11:267-270. doi: 10.2147/IJNRD.S150539. eCollection 2018.
4
A review of clinical characteristics and genetic backgrounds in Alport syndrome.
Clin Exp Nephrol. 2019 Feb;23(2):158-168. doi: 10.1007/s10157-018-1629-4. Epub 2018 Aug 20.
5
Expert consensus guidelines for the genetic diagnosis of Alport syndrome.
Pediatr Nephrol. 2019 Jul;34(7):1175-1189. doi: 10.1007/s00467-018-3985-4. Epub 2018 Jul 9.
7
Midterm Outcome of Kidney Transplantation From Donors With Thin Basement Membrane Nephropathy.
Transplantation. 2018 Apr;102(4):e180-e184. doi: 10.1097/TP.0000000000002089.
10
Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.
J Am Soc Nephrol. 2013 Feb;24(3):364-75. doi: 10.1681/ASN.2012020148. Epub 2013 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验